Salvia miltiorrhiza Bunge as a Potential Natural Compound against COVID-19

Three salvianolic acids inhibit 2019‐nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2

(2021) Shiling Hu et al.   JOURNAL OF MEDICAL VIROLOGY

Tanshinone I and Tanshinone IIA/B attenuate LPS-induced mastitis via regulating the NF-κB

(2021) Lili Yang et al.   BIOMEDICINE & PHARMACOTHERAPY

Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation

(2021) Wei Wang et al.   ACTA PHARMACOLOGICA SINICA

Severe COVID-19 is characterized by the co-occurrence of moderate cytokine inflammation and severe monocyte dysregulation

(2021) Benjamin Bonnet et al.   EBioMedicine

Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs

(2020) Hui Luo et al.   Chinese Journal of Integrative Medicine

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

(2020) Carly G.K. Ziegler et al.   CELL

Cryptotanshinone reverses the epithelial‐mesenchymal transformation process and attenuates bleomycin‐induced pulmonary fibrosis

(2020) Qianyu Zhang et al.   PHYTOTHERAPY RESEARCH

Therapeutic options of TCM for organ injuries associated with COVID-19 and the underlying mechanism

(2020) Jia-Li Zhang et al.   PHYTOMEDICINE

Tanshinone IIA attenuates neuroinflammation via inhibiting RAGE/NF-κB signaling pathway in vivo and in vitro

(2020) Bo Ding et al.   Journal of Neuroinflammation

Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor

(2020) Jinsung Yang et al.   Nature Communications

Antinociceptive and anti-inflammatory effects of cryptotanshinone through PI3K/Akt signaling pathway in a rat model of neuropathic pain

(2019) Wenjia Zhang et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Dihydrotanshinone exhibits an anti-inflammatory effect in vitro and in vivo through blocking TLR4 dimerization

(2019) Renyikun Yuan et al.   PHARMACOLOGICAL RESEARCH

Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway

(2019) Zhuo Chen et al.   Frontiers in Pharmacology

Safe, high-throughput screening of natural compounds of MERS-CoV entry inhibitors using a pseudovirus expressing MERS-CoV spike protein

(2018) Ji Yeun Kim et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Synergistic effects of ultraviolet-B and methyl jasmonate on tanshinone biosynthesis in Salvia miltiorrhiza hairy roots

(2016) Cong Hui Wang et al.   JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

Tanshinone IIA Attenuates Bleomycin-Induced Pulmonary Fibrosis via Modulating Angiotensin-Converting Enzyme 2/ Angiotensin-(1-7) Axis in Rats

(2014) Huajie Wu et al.   International Journal of Medical Sciences

Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases

(2012) Ji-Young Park et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Lipid-soluble Extracts from Salvia miltiorrhiza Inhibit Production of LPS-induced Inflammatory Mediators via NF-κB Modulation in RAW 264.7 Cells and Perform Antiinflammatory Effects In Vivo

(2012) Meng Li et al.   PHYTOTHERAPY RESEARCH

Tanshinone biosynthesis in Salvia miltiorrhiza and production in plant tissue cultures

(2010) Jian Wen Wang et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY